Targeted AML therapy: new biologic paradigms and therapeutic opportunities.
Willman
C L
CL
University of New Mexico Health Sciences Center and Cancer Center, Albuquerque, USA.
D019175:DNA Methylation; D020869:Gene Expression Profiling; D056572:Histone Deacetylase Inhibitors; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy* / Q000235:genetics; D009363:Neoplasm Proteins / Q000502:physiology; D015514:Oncogene Proteins, Fusion / Q000502:physiology; D014178:Translocation, Genetic; D014212:Tretinoin / Q000627:therapeutic use
D056572:Histone Deacetylase Inhibitors; D009363:Neoplasm Proteins; D015514:Oncogene Proteins, Fusion; C093476:promyelocytic leukemia-retinoic acid receptor alpha fusion oncoprotein; D014212:Tretinoin